chiron vaccine

Known as: chiron 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
After about 70 years two new adjuvants have been approved for human vaccines. The first is MF59 developed by the ex-Chiron now… (More)
  • figure 1
Is this relevant?
Review
2004
Review
2004
Herpes simplex virus type 2 (HSV-2) is a suitable target for a vaccine, despite available antiviral therapies, because the virus… (More)
Is this relevant?
2003
2003
A randomised, open study was carried out among an elderly population in order to compare the reactogenicity and immunogenicity of… (More)
Is this relevant?
2003
2003
PURPOSE Trastuzumab as a single agent has activity in metastatic breast cancer; however, the mechanism of action for this… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Elderly people and subjects with underlying chronic diseases are at increased risk for influenza and related complications… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND In 1992-1993, a randomized, double-blind, placebo-controlled clinical trial of two 3-component acellular pertussis… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
1999
Highly Cited
1999
CONTEXT In the last 3 decades, herpes simplex virus type 2 (HSV-2) infection seroprevalence and neonatal herpes have increased… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1999
Highly Cited
1999
PURPOSE To evaluate the efficacy and safety of a slow-release formulation of cytarabine (DepoCyt; Chiron Corp, Emeryville, CA… (More)
Is this relevant?
1999
1999
AIM Helicobacter pylori is associated with gastric cancer. Our aim was to investigate whether CagA or VacA seropositivity… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Hepatitis C virus (HCV) is a major causative agent of posttransfusion non-A, non-B hepatitis, which often develops into malignant… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 5
  • table 2
Is this relevant?